PubMed:33045596 / 1398-1700 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T10 84-92 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 266-274 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 285-301 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T17 188-189 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T22 17-35 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T23 60-64 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T25 65-74 Chemical denotes ionophore http://purl.obolibrary.org/obo/CHEBI_24869
T26 75-79 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T27 190-194 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T29 195-204 Chemical denotes ionophore http://purl.obolibrary.org/obo/CHEBI_24869
T30 209-229 Chemical denotes anti-infective agent http://purl.obolibrary.org/obo/CHEBI_35441

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T11 65-74 http://purl.obolibrary.org/obo/GO_0022809 denotes ionophore
T12 195-204 http://purl.obolibrary.org/obo/GO_0022809 denotes ionophore
T13 285-301 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
42 17-35 Chemical denotes hydroxychloroquine MESH:D006886
43 37-40 Chemical denotes HCQ MESH:D006886
44 84-92 Disease denotes COVID-19 MESH:C000657245
45 174-184 Chemical denotes hinokitiol MESH:C009479
46 266-274 Disease denotes COVID-19 MESH:C000657245
47 285-301 Disease denotes viral infections MESH:D001102

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 0-302 Sentence denotes Considering that hydroxychloroquine (HCQ), the most studied zinc ionophore drug for COVID-19, is linked to potentially serious side effects, we propose the implementation of hinokitiol as a zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and other viral infections.